Bristol Myers Squibb
Registered Principal Details
Business Or Interest:
Pharmaceutical company
Lobbying Interests:
Issues affecting the health care and pharmaceutical industry.
CEO Name:
Chris Boerner
Pharmaceutical company
Lobbying Interests:
Issues affecting the health care and pharmaceutical industry.
CEO Name:
Chris Boerner
Contact
GP
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Genevieve Plumadore | Exclusive Duties No | Authorized On 2/6/2026 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 173
Toggle details
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
2/12/2026
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
Other
Notification Date2/12/2026
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 673
Toggle details
Assembly Bill 673
Relating to: banning the use of genetic software from foreign adversaries in medical and research facilities, the storage of any human genome sequencing data within the borders of a foreign adversary, and providing a penalty. (FE)
Bill Text and History
2/12/2026
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: banning the use of genetic software from foreign adversaries in medical and research facilities, the storage of any human genome sequencing data within the borders of a foreign adversary, and providing a penalty. (FE)
Bill Text and History
Other
Notification Date2/12/2026
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 969
Toggle details
Assembly Bill 969
Relating to: the drug repository program.
Bill Text and History
2/12/2026
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: the drug repository program.
Bill Text and History
Other
Notification Date2/12/2026
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
No certified reports found.
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.